Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Wright Reports
$75.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Valeant Pharmaceuticals International Inc To Syndicate Incremental Loans


Friday, 14 Sep 2012 08:01am EDT 

Valeant Pharmaceuticals International Inc announced plans to syndicate an additional $1,000,000,000 of incremental term B loans under existing senior secured credit facilities. The incremental term B loans will be used to provide a portion of the financing for Valeant's anticipated acquisition of all of the outstanding common stock of Medicis Pharmaceutical Corporation. The incremental term B loans will have a seven year term and are expected to have terms that are substantially similar to the Company's existing Term Loan B facility. The incremental term B loans are expected to close in the first half of 2013, concurrent with the closing of the transaction. The Company also intends to raise approximately $500,000,000 of unsecured debt for general corporate purposes, including acquisitions. 

Company Quote

120.68
-0.26 -0.22%
10 Jul 2014